Abnormal uterine bleeding / heavy menstrual bleeding management
HMB · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Heavy menstrual bleeding affecting quality of life is managed by treating underlying structural or non-structural causes (PALM-COEIN framework), with medical options tried before surgery in most women.
Red flags
- Postmenopausal bleeding
- Intermenstrual or postcoital bleeding
- Rapidly enlarging pelvic mass
- Persistent bleeding despite treatment
- Symptomatic severe anaemia
Assessment
Differential diagnosis
- Dysfunctional/ovulatory dysfunction bleeding
- Fibroids
- Endometrial polyp
- Adenomyosis
- Endometrial hyperplasia or malignancy
- Coagulopathy (e.g. von Willebrand disease)
- Hypothyroidism
Investigations
- FBC for iron deficiency anaemia
- Pelvic examination and cervical screening if due
- Transvaginal ultrasound for structural causes
- Endometrial biopsy if age over 45, risk factors, or treatment failure
- Coagulation/von Willebrand screen if bleeding since menarche or family history
- Thyroid function if clinically indicated
Management
- Take a menstrual and bleeding history and assess impact on quality of life
- Examine and arrange ultrasound to identify structural causes
- Correct iron deficiency anaemia
- Sample the endometrium where malignancy risk is raised
- Offer the levonorgestrel intrauterine system as first-line medical treatment where appropriate
- Offer non-hormonal options (tranexamic acid, mefenamic acid) for women wanting to conceive or avoid hormones
- Offer combined hormonal contraception or oral/long-acting progestogens as alternatives
- Treat structural causes directly (e.g. polypectomy, myomectomy, uterine artery embolisation)
- Consider endometrial ablation or hysterectomy if medical therapy fails and family complete
Drugs & doses
Levonorgestrel intrauterine system 52 mg (first-line)
Tranexamic acid 1 g PO three to four times daily during menses
Mefenamic acid 500 mg PO three times daily during menses
Norethisterone 5 mg PO three times daily (days 5-26) for short-term control; combined pill as an option
Disposition
Primary care initiation of medical therapy; refer to gynaecology for structural pathology, treatment failure, or suspected malignancy, and urgently for postmenopausal bleeding.
Complications & pitfalls
- Iron deficiency anaemia
- Reduced quality of life
- Missed endometrial pathology
- Treatment side effects
- Recurrence after conservative treatment
Exam pearls
- The levonorgestrel intrauterine system is the most effective medical treatment and reduces bleeding by about 90%
- Tranexamic acid and NSAIDs are useful when hormones are unwanted
- Biopsy the endometrium in women over 45 or with risk factors before ablation
- Investigate intermenstrual and postcoital bleeding separately as they suggest other pathology
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.